Articles with public access mandates - Chris DenningLearn more
Not available anywhere: 4
Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening
E Dick, D Rajamohan, J Ronksley, C Denning
Biochemical Society Transactions 38 (4), 1037-1045, 2010
Mandates: British Heart Foundation
Non-invasive label-free monitoring the cardiac differentiation of human embryonic stem cells in-vitro by Raman spectroscopy
FC Pascut, S Kalra, V George, N Welch, C Denning, I Notingher
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (6), 3517-3524, 2013
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Unlocking personalized biomedicine and drug discovery with human induced pluripotent stem cell–derived cardiomyocytes: fit for purpose or forever elusive?
T De Korte, PA Katili, NAN Mohd Yusof, BJ Van Meer, U Saleem, ...
Annual review of pharmacology and toxicology 60 (1), 529-551, 2020
Mandates: German Research Foundation, British Heart Foundation, UK Medical Research …
Rapid micropatterning of cell lines and human pluripotent stem cells on elastomeric membranes
I Paik, DJ Scurr, B Morris, G Hall, C Denning, MR Alexander, ...
Biotechnology and bioengineering 109 (10), 2630-2641, 2012
Mandates: British Heart Foundation
Available somewhere: 98
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
E Matsa, D Rajamohan, E Dick, L Young, I Mellor, A Staniforth, C Denning
European heart journal 32 (8), 952-962, 2011
Mandates: British Heart Foundation
Small molecule absorption by PDMS in the context of drug response bioassays
BJ Van Meer, H de Vries, KSA Firth, J van Weerd, LGJ Tertoolen, ...
Biochemical and biophysical research communications 482 (2), 323-328, 2017
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
C Denning, V Borgdorff, J Crutchley, KSA Firth, V George, S Kalra, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (7), 1728-1748, 2016
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo
L Sala, BJ Van Meer, LGJ Tertoolen, J Bakkers, M Bellin, RP Davis, ...
Circulation research 122 (3), e5-e16, 2018
Mandates: US National Institutes of Health, German Research Foundation, Netherlands …
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for …
D Mosqueira, I Mannhardt, JR Bhagwan, K Lis-Slimak, P Katili, E Scott, ...
European heart journal 39 (43), 3879-3892, 2018
Mandates: US National Institutes of Health, German Research Foundation, British Heart …
N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells
A Abakir, TC Giles, A Cristini, JM Foster, N Dai, M Starczak, ...
Nature genetics 52 (1), 48-55, 2020
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Materials for stem cell factories of the future
AD Celiz, JGW Smith, R Langer, DG Anderson, DA Winkler, DA Barrett, ...
Nature materials 13 (6), 570-579, 2014
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
E Matsa, JE Dixon, C Medway, O Georgiou, MJ Patel, K Morgan, PJ Kemp, ...
European heart journal 35 (16), 1078-1087, 2014
Mandates: UK Biotechnology and Biological Sciences Research Council, British Heart …
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage
Nature biotechnology 29 (12), 1132-1144, 2011
Mandates: Swiss National Science Foundation, Government of Spain
Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease
C Hall, K Gehmlich, C Denning, D Pavlovic
Journal of the American Heart Association 10 (5), e019338, 2021
Mandates: British Heart Foundation, UK Medical Research Council, National Centre for …
Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy
B Lin, Y Li, L Han, AD Kaplan, Y Ao, S Kalra, GCL Bett, RL Rasmusson, ...
Disease models & mechanisms 8 (5), 457-466, 2015
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Current status of drug screening and disease modelling in human pluripotent stem cells
D Rajamohan, E Matsa, S Kalra, J Crutchley, A Patel, V George, ...
Bioessays 35 (3), 281-298, 2013
Mandates: British Heart Foundation
Improved genetic manipulation of human embryonic stem cells
SR Braam, C Denning, S Van Den Brink, P Kats, R Hochstenbach, ...
Nature methods 5 (5), 389-392, 2008
Mandates: US National Institutes of Health
Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides
JE Dixon, G Osman, GE Morris, H Markides, M Rotherham, Z Bayoussef, ...
Proceedings of the National Academy of Sciences 113 (3), E291-E299, 2016
Mandates: UK Biotechnology and Biological Sciences Research Council, British Heart …
Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification
SR Braam, C Denning, E Matsa, LE Young, R Passier, CL Mummery
Nature protocols 3 (9), 1435-1443, 2008
Mandates: British Heart Foundation
Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation
AD Celiz, JGW Smith, AK Patel, AL Hook, D Rajamohan, VT George, ...
Advanced Materials (Deerfield Beach, Fla.) 27 (27), 4006, 2015
Mandates: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Publication and funding information is determined automatically by a computer program